Basiliximab

From WikiMD.org
Jump to navigation Jump to search

Basiliximab

Basiliximab (pronounced as ba-si-lix-i-mab) is a monoclonal antibody used primarily in the prevention of early acute rejection episodes in renal transplantation.

Etymology

The name "Basiliximab" is derived from the Latin word 'basilica', meaning 'royal', and 'iximab', a suffix used in the naming of monoclonal antibodies.

Usage

Basiliximab is used in combination with cyclosporine, corticosteroids, and azathioprine in patients who are undergoing a kidney transplant. It works by blocking the action of a certain protein in the body that can affect the immune system, thus helping to prevent the body from rejecting the transplanted organ.

Related Terms

  • Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Acute Rejection: A type of organ rejection that occurs shortly after the transplant.
  • Transplantation: The process of transferring cells, tissues, or organs from one site to another.
  • Cyclosporine: A medication used to suppress the immune system and prevent the body from rejecting a transplanted organ.
  • Corticosteroids: A class of drugs that lower inflammation in the body.
  • Azathioprine: A medication used to prevent the body from rejecting a transplanted organ.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski